1266798

Amphastar Pharmaceuticals, Inc. — FEI 3002936358

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 3, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rancho Cucamonga, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)